
|Articles|May 1, 2007
Practice management in the era of anti-VEGF therapy (Part I)
Identifying the bottlenecks that are preventing effective management of neovascular AMD.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Patent granted to Kiora Pharmaceuticals' KIO-100 formulations
2
From skepticism to clarity and focus: A family’s PRESBYOND experience
3
Celltrion’s EYLEA-referencing biosimilar, EYDENZELT, receives Canadian approval
4
How Digital Workflow Boosted my Confidence and Elevated Premium Patient Rates in Cataract Surgery
5















































